Table 2.
Utilisation of established monocyte subsets in disease states.
| No of Subsets | Disease | Identifying Markers | Method Used | Reference | Year |
|---|---|---|---|---|---|
| Sepsis | CD14++ (regular) CD14+CD16+ |
2 and 3-colour immunofluorescence, cell sorting | [59] | 1993 | |
| 2 | HIV/AIDS | CD14highCD16low CD14lowCD16high |
Flow cytometry | [60] | 1995 |
| Haemodialysis | CD14++ CD14+CD16+ |
Flow cytometry, phagocytic activity | [61] | 1998 | |
| Haemodialysis | CD14++CD16− CD14++CD16+ CD14+CD16+ |
Flow cytometry | [62] | 2008 | |
| 3 | Asthma | CD14++CD16− CD14++CD16+ CD14+CD16+ |
Flow cytometry | [69] | 2008 |
| Chronic Kidney disease | CD14++CD16− CD14++CD16+ CD14+CD16+ |
Multi-colour flow cytometry | [70] | 2018 |